Antitumor Activity and Pharmacokinetics of TAS-106, 1-(3-C-Ethyny1-β-D-ribo-pentofuranosyl)cytosine
-
- SHIMAMOTO Yuji
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- FUJIOKA Akio
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- KAZUNO Hiromi
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- MURAKAMI Yuko
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- OHSHIMO Hideyuki
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- KATO Toshiyuki
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
-
- MATSUDA Akira
- Graduate School of Pharmaceutical Sciences, Hokkaido University
-
- SASAKI Takuma
- Cancer Research Institute, Kanazawa University
-
- FUKUSHIMA Masakazu
- The Secand Cancer Research Laboratory, Taiho Pharmaceutical Co., Ltd
この論文をさがす
収録刊行物
-
- Japanese journal of cancer research : gann
-
Japanese journal of cancer research : gann 92 (3), 343-351, 2001-03-31
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1572543024535152640
-
- NII論文ID
- 10008061514
-
- NII書誌ID
- AA00690844
-
- ISSN
- 09105050
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles